TheraRadar
← Back
Data updated: Mar 29, 2026

WATSON LABS

CardiovascularInfectious DiseaseDermatology
Generics

WATSON LABS is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Dermatology.

1971
Since
393
Drugs
-
Trials
3143
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 43%
28 drugs
Infectious Disease 15%
10 drugs
Dermatology 14%
9 drugs
Neurology 14%
9 drugs
Immunology 14%
9 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...